Lepirudin in the management of patients with heparin-induced thrombocytopenia

References

• Bayer Inc2007Product Monograph Refludan®Toronto
   Google Scholar
• BeckerRC2000Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass graftingJ Thromb Thrombolysis10Suppl 1596811155195
   PubMed Web of Science ®Google Scholar
• BoningAMorschheuserTBlaseU2005Incidence of heparin-induced thrombocytopenia and therapeutic strategies in pediatric cardiac surgeryAnn Thorac Surg7962515620916
   PubMed Web of Science ®Google Scholar
• BoveCMCaseyBMarderVJ1996DDAVP reduces bleeding during continued hirudin administration in the rabbitThromb Haemost7547158701410
   PubMed Web of Science ®Google Scholar
• BuchaEKremlRNowakG1999aIn vitro study of r-hirudin permeability through membranes of different haemodialysersNephrol Dial Transplant142922610570098
   PubMed Web of Science ®Google Scholar
• BuchaENowakGCzerwinskiR1999bR-hirudin as anticoagulant in regular hemodialysis therapy:finding of therapeutic R-hirudin blood/plasma concentrations and respective dosagesClin Appl Thromb Hemost51647010726003
   PubMed Web of Science ®Google Scholar
• ButlerKDDolanSLTalbotMD1993Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the ratBlood Coagul Fibrinolysis4459648329573
   PubMed Web of Science ®Google Scholar
• CreekmoreFMOderdaGMPendletonRC2006Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolismPharmacotherapy2614384516999654
   PubMed Web of Science ®Google Scholar
• CrowtherMACookDJMeadeMO2005Thrombocytopenia in medical-surgical critically ill patients:prevalence, incidence, and risk factorsJ Crit Care203485316310606
   PubMed Web of Science ®Google Scholar
• DeitcherSRTopoulosAPBartholomewJR2002Lepirudin anticoagulation for heparin-induced thrombocytopeniaJ Pediatr140264611865285
   PubMed Web of Science ®Google Scholar
• DodtJMüllerHPSeemüllerU1984The complete amino acid sequence of hirudin, a thrombin specific inhibitorFEBS1651804
   Web of Science ®Google Scholar
• EichlerPFriesenHJLubenowN2000Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevanceBlood962373811001886
   PubMed Web of Science ®Google Scholar
• EngelmannFStadeC1909Über die Bedeutung des Blutegelextraktes für die Therapie der EklampsieMünch Med Wochenschr4322037
   Google Scholar
• FabrizioMC2001Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypassJ Extra Corpor Technol331172511467439
   PubMedGoogle Scholar
• FarnerBEichlerPKrollH2001A comparison of danaparoid and lepirudin in heparin-induced thrombocytopeniaThromb Haemost85950711434701
   PubMed Web of Science ®Google Scholar
• FischerKGLiebeVHudekR2003Anti-hirudin antibodies alter pharmacokinetics and pharmacodynamics of recombinant hirudinThromb Haemost899738212783109
   PubMed Web of Science ®Google Scholar
• FischerKGvan de LooABohlerJ1999Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysisKidney Int56S4650
   Web of Science ®Google Scholar
• GajraAVajpayeeNSmithA2007Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapyAm J Hematol82391317109386
   PubMed Web of Science ®Google Scholar
• GirolamiBGirolamiA2006Heparin-induced thrombocytopenia:a reviewSemin Thromb Hemost32803917171593
   PubMed Web of Science ®Google Scholar
• GirolamiBPrandoniPStefaniPM2003The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort studyBlood1012955912480713
   PubMed Web of Science ®Google Scholar
• GreinacherA2004Lepirudin for the treatment of heparin-induced thrombocytopeniaWarkentinTEGreinacherAHeparin-induced throm-bocytopenia3rd edNew York, BaselMarcel Dekker397436
   Google Scholar
• GreinacherA2006Heparin-induced thrombocytopenia: frequency and pathogenesisPathophysiol Haemost Thromb35374516855345
   PubMedGoogle Scholar
• GreinacherAEichlerPAlbrechtD2003aAntihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery:incidence and clinical relevanceBlood1012617912393696
   PubMed Web of Science ®Google Scholar
• GreinacherAJanssensUBergG1999aLepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigatorsCirculation1005879310441094
   PubMed Web of Science ®Google Scholar
• GreinacherAJuhlDStrobelU2007Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classesJ Thromb Haemost516667317488345
   PubMed Web of Science ®Google Scholar
• GreinacherALubenowNEichlerP2003bAnaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopeniaCirculation1082062514568897
   PubMed Web of Science ®Google Scholar
• GreinacherAVolpelHJanssensU1999bRecombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia:a prospective studyCirculation9973809884382
   PubMed Web of Science ®Google Scholar
• HafnerGRoserMNauckM2002Methods for the monitoring of direct thrombin inhibitorsSemin Thromb Hemost284253012420237
   PubMed Web of Science ®Google Scholar
• HaycraftJB1884On the action of a secretion obtained from the medicinal leech on the coagulation of the bloodProc R Soc Lond3647887
   Google Scholar
• HeinOVvon HeymannCMorgeraS2005Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failureArtif Organs295071015926989
   PubMed Web of Science ®Google Scholar
• HemkerHCAl DieriRDe SmedtE2006Thrombin generation, a function test of the haemostatic-thrombotic systemThromb Haemost965536117080210
   PubMed Web of Science ®Google Scholar
• HoffmanMMonroeDM3rd2001A cell-based model of hemostasisThromb Haemost859586511434702
   PubMed Web of Science ®Google Scholar
• HuhleGGeberthMHoffmannU2000Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudinGynecol Obstet Invest4967910629377
   PubMed Web of Science ®Google Scholar
• HuhleGHoffmannUSongX1999Immunologic response to recombinant hirudin in HIT type II patients during long-term treatmentBr J Haematol10619520110444187
   PubMed Web of Science ®Google Scholar
• HutchisonCADasguptaI2007National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK populationNephrol Dial Transplant221680417371779
   PubMed Web of Science ®Google Scholar
• IbbotsonSHGrantPJKerryR1991The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on the anticoagulant effect of recombinant hirudin (CGP39393) in vitroThromb Haemost656461902596
   PubMed Web of Science ®Google Scholar
• JohnstonNJessenMEDiMaioM1999The emergency use of recombinant hirudin in cardiopulmonary bypassJ Extra Corpor Technol31211510915479
   PubMedGoogle Scholar
• JuhlDEichlerPLubenowN2006Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopeniaEur J Haematol76420616466367
   PubMed Web of Science ®Google Scholar
• KlennerAFFuschCRakowA2003Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trialJ Pediatr143741514657819
   PubMed Web of Science ®Google Scholar
• KlennerAFGreinacherA2004Heparin-induced thrombocytopenia in childrenWarkentinTEGreinacherAHeparin-induced thrombocytopenia3rd edNew York, BaselMarcel Dekker55371
   Google Scholar
• KnodererCAKnodererHMTurrentineMW2006Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patientPharmacotherapy267091216718945
   PubMed Web of Science ®Google Scholar
• KosterAHansenRKuppeH2000aRecombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patientsJ Cardiothorac Vasc Anesth14243810890473
   PubMed Web of Science ®Google Scholar
• KosterALoebeMHansenR2000bA quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: adaptation of the ecarin clotting time to the act II deviceJ Thorac Cardiovasc Surg11912788310838548
   PubMed Web of Science ®Google Scholar
• KosterAMerkleFHansenR2000cElimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass:assessment of different filter systemsAnesth Analg91265910910829
   PubMed Web of Science ®Google Scholar
• LiebeVBruckmannMFischerKG2002Biological relevance of anti-recombinant hirudin antibodies – results from in vitro and in vivo studiesSemin Thromb Hemost284839012420244
   PubMed Web of Science ®Google Scholar
• Lindhoff-LastEBauersachsR2002Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactationSemin Thromb Hemost284394612420239
   PubMed Web of Science ®Google Scholar
• Lindhoff-LastEPiechottkaGPRabeF2000aHirudin determination in plasma can be strongly influenced by the prothrombin levelThromb Res100556011053617
   PubMed Web of Science ®Google Scholar
• Lindhoff-LastEWillekeAThalhammerC2000bHirudin treatment in a breastfeeding womanLancet355467810841132
   PubMed Web of Science ®Google Scholar
• LiuHFlemingNWMoorePG2002Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypassJ Clin Anesth14452512393116
   PubMed Web of Science ®Google Scholar
• LubenowNEichlerPLietzT2005Lepirudin in patients with heparin-induced thrombocytopenia – results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3J Thromb Haemost324283616241940
   PubMed Web of Science ®Google Scholar
• MarkwardtFFinkGKaiserB1988Pharmacological survey of recombinant hirudinPharmazie4320273380865
   PubMed Web of Science ®Google Scholar
• MarkwardtFNowakGSturzebecherJ1991Clinical pharmacology of recombinant hirudinHaemostasis21Suppl 113361894188
   PubMedGoogle Scholar
• MarkwardtFNowakGSturzebecherJ1984Pharmacokinetics and anticoagulant effect of hirudin in manThromb Haemost5216036523433
   PubMed Web of Science ®Google Scholar
• MartelNLeeJWellsPS2005Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophy-laxis: a meta-analysisBlood1062710515985543
   PubMed Web of Science ®Google Scholar
• MeyerBHLuusHGMullerFO1990The pharmacology of recombinant hirudin, a new anticoagulantS Afr Med J78268702392724
   PubMed Web of Science ®Google Scholar
• MoserMRueJPeterK2001Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activityJ Thromb Thrombolysis12165911729368
   PubMed Web of Science ®Google Scholar
• NewallFBarnesCIgnjatovicV2003Heparin-induced thrombocytopenia in childrenJ Paediatr Child Health392899212755937
   PubMed Web of Science ®Google Scholar
• NguyenTNGalPRansomJL2003Lepirudin use in a neonate with heparin-induced thrombocytopeniaAnn Pharmacother372293312549954
   PubMed Web of Science ®Google Scholar
• NowakG2001Clinical monitoring of hirudin and direct thrombin inhibitorsSemin Thromb Hemost275374111668425
   PubMed Web of Science ®Google Scholar
• NowakGBuchaE1996Quantitative determination of hirudin in blood and body fluidsSemin Thromb Hemost221972028807717
   PubMed Web of Science ®Google Scholar
• NowakGBuchaEBraunsI1997Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patientWien Klin Wochenschr10935489200807
   PubMed Web of Science ®Google Scholar
• NowakGBuchaEGoockT1992Pharmacology of r-hirudin in renal impairmentThromb Res66707151519229
   PubMed Web of Science ®Google Scholar
• NowakGMarkwardtFFinkE1988Pharmacokinetic studies with recombinant hirudin in dogsFolia Haematol Int Mag Klin Morphol Blutforsch1157042459035
   PubMedGoogle Scholar
• OhJJAkersWSLewisD2006Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudinPharmacotherapy265697716553518
   PubMed Web of Science ®Google Scholar
• PetrosSSiegemundTSiegemundA2006The effect of different anticoagulants on thrombin generationBlood Coagul Fibrinolysis17131716479195
   PubMed Web of Science ®Google Scholar
• PötzschBHundSMadlenerK1997aMonitoring of recombinant hirudin:assessment of a plasma-based ecarin clotting time assayThromb Res8637383
   PubMed Web of Science ®Google Scholar
• PötzschBMadlenerKSeeligC1997bMonitoring of r-hirudin anticoagulation during cardiopulmonary bypass – assessment of the whole blood ecarin clotting timeThromb Haemost779205
   PubMed Web of Science ®Google Scholar
• PrandoniPSiragusaSGirolamiB2005The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin:a prospective cohort studyBlood10630495416030191
   PubMed Web of Science ®Google Scholar
• RiessFCPoetzschBMadlenerK2007Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot studyThorac Cardiovasc Surg55233817546553
   PubMed Web of Science ®Google Scholar
• RobertsHRHoffmanMMonroeDM2006A cell-based model of thrombin generationSemin Thromb Hemost32Suppl 132816673264
   PubMed Web of Science ®Google Scholar
• SanerFHertlMBroelschCE2001Anticoagulation with hirudin for continuous veno-venous hemodialysis in liver transplantationActa Anaesthesiol Scand45914811472297
   PubMed Web of Science ®Google Scholar
• SchieleFVuillemenotAKramarzP1994A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosisThromb Haemost71558628091380
   PubMed Web of Science ®Google Scholar
• SellengKWarkentinTEGreinacherA2007Heparin-induced thrombocytopenia in intensive care patientsCrit Care Med3511657617334253
   PubMed Web of Science ®Google Scholar
• SeverinTZiegerBSutorAH2002Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patientsSemin Thromb Hemost284475412420240
   PubMed Web of Science ®Google Scholar
• SmytheMAKoerberJMMattsonJC2007The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospitalChest1311644917400685
   PubMed Web of Science ®Google Scholar
• SmytheMAStephensJLKoerberJM2005A comparison of lepirudin and argatroban outcomesClin Appl Thromb Hemost11371416244762
   PubMed Web of Science ®Google Scholar
• StraussRWehlerMMehlerK2002Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcomeCrit Care Med3017657112163790
   PubMed Web of Science ®Google Scholar
• VanholderRCamezAVeysN1997Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patientsThromb Haemost7765059134637
   PubMed Web of Science ®Google Scholar
• VerstraeteMNurmohamedMKienastJ1993Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis GroupJ Am Coll Cardiol22108088409044
   PubMed Web of Science ®Google Scholar
• WallisDEWorkmanDLLewisBE1999Failure of early heparin cessation as treatment for heparin-induced thrombocytopeniaAm J Med1066293510378620
   PubMed Web of Science ®Google Scholar
• WarkentinTE2003Management of heparin-induced thrombocytopenia:a critical comparison of lepirudin and argatrobanThromb Res110738212893020
   PubMed Web of Science ®Google Scholar
• WarkentinTE2004An overview of the heparin-induced thrombocytopenia syndromeSemin Thromb Hemost302738315282649
   PubMed Web of Science ®Google Scholar
• WarkentinTEHeddleNM2003Laboratory diagnosis of immune heparin-induced thrombocytopeniaCurr Hematol Rep21485712901146
   PubMedGoogle Scholar
• WarkentinTELevineMNHirshJ1995Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparinN Engl J Med332133057715641
   PubMed Web of Science ®Google Scholar
• WeitzJIHudobaMMasselD1990Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitorsJ Clin Invest86385912384594
   PubMed Web of Science ®Google Scholar
• YamamotoSKoideMMatsuoM1996Heparin-induced thrombocytopenia in hemodialysis patientsAm J Kidney Dis288258712226
   PubMed Web of Science ®Google Scholar